Mutation analysis of the MDM4 gene in German breast cancer patients

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Reincke, Scarlett ^a   Govbakh, Lina ^a   Wilhelm, Bettina ^a   Jin, Haiyan ^a   Bogdanova, Natalia ^a   Bremer, Michael ^a   Karstens, Johann H ^a   Dörk, Thilo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDMX; MDM4 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CULTURE MEDIUM; DNA SEQUENCE; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GERMANY; HUMAN; INTRON; MDM4 GENE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTITUTION LINE; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CASE CONTROL STUDY; FAMILY; GENETICS; MIDDLE AGED; MOLECULAR GENETICS;

BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; GENETIC SCREENING; GERMANY; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS;

EID: 40349093193     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-52     Document Type: Article

References (50)

1. Lane DP p53, guardian of the genome Nature 1992, 358:15-16 10.1038/ 358015a0 1614522
2. Levine AJ p53, the cellular gatekeeper for growth and division Cell 1997, 88:323-331 10.1016/S0092-8674(00)81871-1 9039259
3. Vousden KH Lu X Live or let die: The cell's response to p53 Nat Rev Cancer 2002, 2:594-604 10.1038/nrc864 12154352
4. Brooks CL Gu W Ubiquitination, phosphorylation and acetylation: The molecular basis for p53 regulation Curr Opin Cell Biol 2003, 15:164-171 10.1016/S0955-0674(03)00003-6 12648672
5. Lavin MF Gueven N The complexity of p53 stabilization and activation Cell Death Differ 2006, 13:941-950 10.1038/sj.cdd.4401925 16601750
6. Marine J-C Francoz S Maetens M Wahl G Toledo F Lozano G Keeping p53 in check: Essential and synergistic functions of Mdm2 and MdmX Cell Death Differ 2006, 13:927-934 10.1038/sj.cdd.4401912 16543935
7. Toledo F Wahl GM Regulating the p53 pathway: In vitro hypothesis, in vivo veritas Nat Rev Cancer 2006, 6:909-923 10.1038/nrc2012 17128209
8. Marine J-C Dyer MA Jochemsen AG MDMX: From bench to bedside J Cell Sci 2007, 120:371-378 10.1242/jcs.03362 17251377
9. Wang YV Wade M Wong E Li YC Rodewald LW Wahl GM Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation Proc Natl Acad Sci USA 2007
10. Xiong S Van Pelt CS Elizondo-Fraire AC Liu G Lozano G Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development Proc Natl Acad Sci USA 2006, 103:3226-3231 1413885 16492743 10.1073/pnas.0508500103
11. Chen L Gilkes DM Pan Y Lane WS Chen J ATM- and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage EMBO J 2005, 24:3411-3422 1276172 16163388 10.1038/sj.emboj.7600812
12. Okamoto K Kashima K Pereg Y Ishida M Yamazaki S Nota A Teunisse A Migliorini D Kitabayashi I Marine JC Prives C Shiloh Y Jochemsen AG Taya Y DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation Mol Cell Biol 2005, 25:9608-9620 1265801 16227609 10.1128/MCB.25.21.9608-9620.2005
13. Pereg Y Shkedy D de Graaf P Meulmeester E Edelson-Averbukh M Salek M Biton S Teunisse AF Lehmann WD Jochemsen AG Shiloh Y Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage Proc Natl Acad Sci USA 2005, 102:5056-5061 555986 15788536 10.1073/pnas.0408595102
14. Pereg Y Lam S Teunisse A Biton S Meulmeester E Mittelman L Buscemi G Okamoto K Taya Y Shiloh Y Jochemsen AG Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage Mol Cell Biol 2006, 26:6819-6831 1592859 16943424 10.1128/MCB.00562-06
15. Danovi D Meulmeester E Pasini D Migliorini D Capra M Frenk R de Graaf P Francoz S Gasparini P Gobbi A Helin K Pelicci PG Jochemsen AG Marine JC Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity Mol Cell Biol 2004, 24:5835-5843 480894 15199139 10.1128/MCB.24.13.5835-5843.2004
16. Backe J Hofferbert S Skawran B Dörk T Stuhrmann M Karstens JH Untch M Meindl A Burgemeister R Chang-Claude J Weber BHF Frequency of BRCA1 mutation 5382insC in German breast cancer patients Gynecol Oncol 1999, 72:402-406 10.1006/gyno.1998.5270 10053113
17. Dörk T Bendix R Bremer M Rades D Klöpper K Nicke M Skawran B Hector A Yamini P Steinmann D Weise S Stuhrmann M Karstens JH Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients Cancer Res 2001, 61:7608-7615 11606401
18. The CHEK2 Breast Cancer Case-Control Consortium CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies Am J Hum Genet 2004, 74:1175-82 1182081 15122511 10.1086/421251
19. Bogdanova N Enßen-Dubrowinskaja N Festchenko S Lazijuk S Rogov YI Dammann O Bremer M Karstens JH Sohn C Dörk T Association of two mutations in the CHEK2 gene with breast cancer Int J Cancer 2005, 116:263-266 10.1002/ijc.21022 15810020
20. Bogdanova N Feshchenko S Cybulski C Dörk T CHEK2 mutation and hereditary breast cancer Journal of Clinical Oncology 95:e26
21. The Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium J Natl Cancer Inst 2006, 98:1382-1396 17018785
22. Cox A Dunning AM Garcia-Closas M Balasubramanian S Reed MWR Pooley KA Scollen S Ponder BAJ Chanock S Lissowska J Brinton L Southey MC Hopper JL McCredie MRE Giles GG Fletcher O Johnson N dos Santos Silva I Gibson L Bojesen SE Nordestgaard BG Axelsson CK Torres D Hamann U Justenhoven C Brauch H Chang-Claude J Kropp S Risch A Wang-Gohrke S Schürmann P Bogdanova N Dörk T Fagerholm R Aaltonen K Blomqvist C Nevanlinna H Seal S The Breast Cancer Susceptibility Collaboration (UK) Stratton MR Rahman N Sangrajrang S Hughes D Odefrey F Brennan P Spurdle AB Chenevix-Trench G Beesley J The Katherine Cunningham Foundation Consortium for Research into Familial Breast Cancer Mannermaa A Hartikainen J Kataja V Kosma V-M Couch FJ Olson J Goode EL Broeks A Schmidt MK Hogervorst FBL Van't Veer LJ Kang D Yoo K-Y Noh D-Y Ahn S-H Wedrén S Hall P Low Y-L Liu J Milne RL Ribas G Gonzalez-Neira A Benitez J Sigurdson AJ Stredrick DL Alexander BH Struewing JP Pharoah PDP Easton DF A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 2007, 39:352-358 10.1038/ng1981 17293864
23. Easton DF Pooley KA Dunning AM Pharoah PDP Thompson D Ballinger DG Struewing JP Morrison J Field H Luben R Wareham N Ahmed S Healey CS Bowman R The S. E. A. R. C. H. collaborators Meyer KB Haiman CA Kolonel LK Henderson BE Le Marchand L Brennan P Sangrajrang S Gaborieau V Odefrey F Shen C-Y Wu P-E Wang H-C Eccles D Gareth Evans D Peto J Fletcher O Johnson N Seal S Stratton MR Rahman N Chenevix-Trench G Bojesen SE Nordestgaard BG Axelsson CK Garcia-Closas M Brinton L Chanock S Lissowska J Peplonska B Nevanlinna H Fagerholm R Eerola H Kang D Yoo K-Y Noh D-Y Ahn S-H Hunter DJ Hankinson SE Cox DG Hall P Wedren S Liu J Low Y-L Bogdanova N Schürmann P Dörk T Tollenaar RAEM Jacobi CE Devilee P Klijn JGM Sigurdson AJ Doody MM Alexander BH Zhang J Cox A Brock IW MacPherson G Reed MWR Couch F Goode EL Olson JE Meijers-Heijboer H van den Ouweland A Uitterlinden A Rivadeneira F Milne RL Ribas G Gonzalez-Neira A Benitez J Hopper JL McCredie M Southey M Giles GG Schroen C Justenhoven C Brauch H Hamann U Ko Y-D Spurdle AB Beesley J Chen X kConFab, A. O. C. S. Management Group Mannermaa A Kosma V-M Kataja V Hartikainen J Day NE Cox DR Ponder BAJ A genome-wide association study identifies breast cancer susceptibility loci Nature 2007, 447:1087-1093 10.1038/nature05887 17529967
24. Yeo G Burge CB Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals J Comput Biol 2004, 11:377-94 http://genes.mit.edu/cgi-bin/Xmaxentscan_scoreseq.pl 10.1089/1066527041410418 15285897
25. Smith PJ Zhang C Wang J Chew SL Zhang MQ Krainer AR An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers Hum Mol Genet 2006, 15:2490-2508 http://rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi 10.1093/hmg/ddl171 16825284
26. Giglio S Mancini F Gentiletti F Sparaco G Felicioni L Barassi F Martella C Prodosmo A Iacovelli S Buttitta F Farsetti A Soddu S Marchetti A Sacchi A Pontecorvi A Moretti F Identification of an Aberrantly Spliced Form of HDMX in Human Tumors: A New Mechanism for HDM2 Stabilization Cancer Res 2005, 65:9687-9694 10.1158/0008-5472.CAN-05-0450 16266988
27. Rallapalli R Strachan G Cho B Mercer WE Hall DJ A Novel MDMX Transcript Expressed in a Variety of Transformed Cell Lines Encodes a Truncated Protein with Potent p53 Repressive Activity J Biol Chem 1999, 274:8299-8308 10.1074/jbc.274.12.8299 10075736
28. Levy-Lahad E Lahad A Eisenberg S Dagan E Paperna T Kasinetz L Catane R Kaufman B Beller U Renbaum P Gershoni-Baruch R A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers Proc Natl Acad Sci USA 2001, 98:3232-3236 30636 11248061 10.1073/pnas.051624098
29. Wang WW Spurdle AB Kolachana P Bove B Modan B Ebbers SM Suthers G Tucker MA Kaufman DJ Doody MM Tarone RE Daly M Levavi H Pierce H Chetrit A Yechezkel GH Chenevix-Trench G Offit K Godwin AK Struewing JP A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers Cancer Epidemiol Biomarkers Prev 2001, 10:955-60 11535547
30. Kadouri L Kote-Jarai Z Hubert A Durocher F Abeliovich D Glaser B Hamburger T Eeles RA Peretz T A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers Br J Cancer 2004, 90:2002-2005 10.1038/ sj.bjc.6601837 15138485
31. Jakubowska A Gronwald J Menkiszak J Gorski B Huzarski T Byrski T Edler L Lubinski J Scott RJ Hamann U The RAD51 135G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers Cancer Epidemiol Biomarkers Prev 2007, 16:270-275 10.1158/ 1055-9965.EPI-06-0562 17301259
32. Ng PC Henikoff S Accounting for human polymorphisms predicted to affect protein function Genome Res 2002, 12:436-46 http://blocks.fhcrc.org/sift/ SIFT.html 155281 11875032 10.1101/gr.212802
33. Bairoch A Bucher P Hofmann K The PROSITE database, its status in 1997 Nucl Acids Res 1997, 25:217-221 146371 9016539 10.1093/nar/25.1.217
34. Boersma B Howe T Goodman J Yfantis HG Lee DH Chanock SJ Ambs S Association of Breast Cancer Outcome With Status of p53 and MDM2 SNP309 J Natl Cancer Inst 2006, 98:911-9 16818855
35. Bond GL Hu W Levine A A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect Cancer Res 2005, 65:5481-5484 10.1158/0008-5472.CAN-05-0825 15994915
36. Bougeard G Baert-Desurmont S Tournier I Vasseur S Martin C Brugieres L Chompret A Bressac-de Paillerets B Stoppa-Lyonnet D Bonaiti-Pellie C Frebourg T Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome J Med Genet 2006, 43:531-3 1904480 16258005 10.1136/jmg.2005.037952
37. Copson ER White HE Blaydes JP Robinson DO Johnson PW Eccles DM Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers BMC Cancer 2006, 24:6-80
38. Ohayon T Gershoni-Baruch R Papa MZ Distelman Menachem T Eisenberg Barzilai S Friedman E The R72P P53 mutation is associated with familial breast cancer in Jewish women Br J Cancer 2005, 92:1144-1148 10.1038/ sj.bjc.6602451 15756275
39. Osorio A Martinez-Delgado B Pollan M Cuadros M Urioste M Torrenteras C Melchor L Diez O De La Hoya M Velasco E Gonzalez-Sarmiento R Caldes T Alonso C Benitez J A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers Hum Mutat 2006, 27:242-248 10.1002/humu.20283 16419081
40. NCBI SNP Database, as of May 25, 2006 http://www.ncbi.nlm.nih.gov/sites/ entrez
41. Chamary J-V Parmley JL Hurst LD Hearing silence: Non-neutral evolution at synonymous sites in mammals Nat Rev Genet 2006, 7:98-108 10.1038/ nrg1770 16418745
42. Kotlar D Lavner Y The action of selection on codon bias in the human genome is related to frequency, complexity, and chronology of amino acids BMC Genomics 2006, 7:67 1456966 16584540 10.1186/1471-2164-7-67
43. Kimchi-Sarfaty C Oh JM Kim IW Sauna ZE Calcagno AM Ambudkar SV Gottesman MM A "silent" polymorphism in the MDR1 gene changes substrate specificity Science 2007, 315:525-528 10.1126/science.1135308 17185560
44. Komar AA SNPs, silent but not invisible Science 2007, 315:466-467 10.1126/science.1138239 17185559
45. TFSearch v1.3 http://www.cbrc.jp/htbin/nph-tfsearch
46. Ahmed K Gerber DA Cochet C Joining the cell survival squad: An emerging role for protein kinase CK2 Trends Cell Biol 2002, 12:226-230 10.1016/ S0962-8924(02)02279-1 12062170
47. Meggio F Pinna LA One-thousand and one substrates of protein kinase CK2? FASEB J 2003, 17:349-368 10.1096/fj.02-0473rev 12631575
48. Shanware NP Trinh AT Williams LM Tibbetts RS Coregulated ataxia telangiectasia-mutated and casein kinase sites modulate cAMP-response element-binding protein-coactivator interactions in response to DNA damage J Biol Chem 2007, 282:6283-91 10.1074/jbc.M610674200 17209043
49. Chen L Li C Pan Y Chen J Regulation of p53-MDMX interaction by casein kinase I alpha Mol Cell Biol 2005, 25:6509-6520 1190343 16024788 10.1128/ MCB.25.15.6509-6520.2005
50. Human Genome Variation Society http://www.hgvs.org/mutnomen/